Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 10.06 Delayed Data As of Oct 19 |  -0.01 / -0.10%Today’s Change | 8.24 Today|||52-Week Range 13.30 | +4.25% Year-to-Date |
Latest TEVA News | Press Releases
| Why Humana Is Suing Biogen Oct 09 / MotleyFool.com - Paid Partner Content | 5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter Oct 08 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.07 |
| Today’s open | 9.82 |
| Day’s range | 9.66 - 9.82 |
| Volume | 34,532 |
| Average volume (3 months) | 8,304,333 |
| Market cap | $10.7B |
Data as of 4:28pm ET, 10/19/2021
Growth & Valuation
| Earnings growth (last year) | -297.93% |
| Earnings growth (this year) | +1.11% |
| Earnings growth (next 5 years) | +3.65% |
| Revenue growth (last year) | -1.27% |
| P/E ratio | NM |
| Price/Sales | 0.63 |
| Price/Book | 1.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | -0.69 | -1.44% |
| ---- | ||
| IMMBImmunotech Laborator... | +0.00 | +566.67% |
| BGNEBeigene Ltd | +15.19 | +4.21% |
Data as of 10/18/2021
Financials
| Next reporting date | October 27, 2021 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $16.7B |
| Annual profit (last year) | -$4.0B |
| Net profit margin | -23.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
